CVE-2025-52653: HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the…
CVE-2025-52653 · Severity: high · CVSS 7.6 · Published 2025-10-03
HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the execution of unauthorized scripts, potentially resulting in unauthorized actions or access.
No. Junglewise Threat Intelligence has no report of CVE-2025-52653 being exploited in the wild.
How severe is CVE-2025-52653?
High severity, with a CVSS score of 7.6, published 3 October 2025.
Which products and versions are affected?
Hcltech Dryice Myxalytics. The advisory does not name versions.
Is there a fix for CVE-2025-52653?
No fixed version is recorded yet. Check the vendor's advisory in the references below. If you run it, Junglewise drafts a mitigation that fits your setup and applies it once you approve, with senior security engineers behind it.
Am I affected by CVE-2025-52653?
Check whether you run Hcltech Dryice Myxalytics. Junglewise does that check for you around the clock: connect your code, cloud and domains, and it matches new vulnerabilities like this one against what you actually run and tells you when one reaches you.